Description
(R,S)-Anatabine is a minor alkaloid produced in plants of the Solanaceae family, including tobacco. The detection of (R,S)-anatabine in urine is used as an indicator of tobacco use, particularly when nicotine-
containing products (gum, patches, inhalers, and medications) are also being used. (R,S)-Anatabine increases nicotine self-
administration and locomotor activity in rats. Of note, (R,S)-anatabine diminishes amyloid-β production
in vitro and
in vivo. (R,S)-Anatabine reduces (600 μg/ml) the transcription and protein levels of β-
secretase, lowering the amount of Aβ (1-40) and Aβ (1-42) in a dose dependent manner in SHSY-
5Y cells. (R,S)-Anatabine also dose dependently inhibits NF-
κB activation.
in vitro
anatabine dose-dependently lowered aβ1-40 and aβ1-42 levels and reduced sappβ production without any effects on sappα levels. anatabine lowered aβ production by mainly impacting the β-cleavage of app. anatabine lowered nfκb activation. anatabine inhibited bace-1 transcription and reduced bace-1 protein levels in human neuronal like shsy-5y cells. (r,s)-anatabine also dose dependently inhibits nf-κb activation [1].
References
[1] paris d, beaulieu-abdelahad d, bachmeier c, et al. anatabine lowers alzheimer's aβ production in vitro and in vivo[j]. european journal of pharmacology, 2011, 670(2): 384-391.